Multiplexed Antibody Glycosylation Profiling Using Dual Enzyme Digestion and Liquid Chromatography-Triple Quadrupole Mass Spectrometry Method

采用双酶消化和液相色谱-三重四极杆质谱法进行多重抗体糖基化分析

阅读:56
作者:Yu-Hsuan Cheng, Chih-Hsin Lee, San-Yuan Wang, Chia-Yi Chou, Yun-Jung Yang, Chih-Chin Kao, Hsin-Yi Wu, Yushi Dong, Wen-Ying Hung, Ching-Yi Su, Shih-Ting Tseng, I-Lin Tsai

Abstract

Antibody glycosylation plays a crucial role in the humoral immune response by regulating effector functions and influencing the binding affinity to immune cell receptors. Previous studies have focused mainly on the immunoglobulin G (IgG) isotype owing to the analytical challenges associated with other isotypes. Thus, the development of a sensitive and accurate analytical platform is necessary to characterize antibody glycosylation across multiple isotypes. In this study, we have developed an analytical workflow using antibody-light-chain affinity beads to purify IgG, IgA, and IgM from 16 μL of human plasma. Dual enzymes, trypsin and Glu-C, were used during on-bead digestion to obtain enzymatic glycopeptides and protein-specific surrogate peptides. Ultra-high-performance liquid chromatography coupled with triple quadrupole mass spectrometry was used in order to determine the sensitivity and specificity. Our platform targets 95 glycopeptides across the IgG, IgA, and IgM isotypes, as well as eight surrogate peptides representing total IgG, four IgG classes, two IgA classes, and IgM. Four stable isotope-labeled internal standards were added after antibody purification to calibrate the preparation and instrumental bias during analysis. Calibration curves constructed using serially diluted plasma samples showed good curve fitting (R2 > 0.959). The intrabatch and interbatch precision for all the targets had relative standard deviation of less than 29.6%. This method was applied to 19 human plasma samples, and the glycosylation percentages were calculated, which were comparable to those reported in the literature. The developed method is sensitive and accurate for Ig glycosylation profiling. It can be used in clinical investigations, particularly for detailed humoral immune profiling.

文献解析

1. 文献背景信息  
  标题/作者/期刊/年份  
  “Multiplexed Antibody Glycosylation Profiling Using Dual Enzyme Digestion and Liquid Chromatography-Triple Quadrupole Mass Spectrometry Method”  
  Yu-Hsuan Cheng 等,Molecular & Cellular Proteomics,2024-02(IF≈6.1,ASBMB 旗舰)。  

 

  研究领域与背景  
  抗体糖基化决定其效应功能(ADCC、CDC 等),但现有平台多聚焦 IgG,且对 IgA、IgM 的定量覆盖有限;不同同型抗体糖型差异的临床意义仍未系统阐明。  

 

  研究动机  
  填补“单针微体积(16 μL)同时定量 IgG/IgA/IgM 全糖型”技术空白,为免疫监测、疫苗评价及自身免疫病分型提供高通量工具。

 

2. 研究问题与假设  
  核心问题  
  如何在一次 LC-MS/MS 运行内,准确、灵敏地定量 ≥95 个糖肽和 8 个总抗体亚型,并确保批间可重复性?  

 

  假设  
  通过“轻链亲和磁珠-双酶切-稳定同位素内标”策略,可在 16 μL 血浆中同时获取多同型糖基化指纹,且结果与文献/ELISA 一致。

 

3. 研究方法学与技术路线  
  实验设计  
  方法学开发与临床验证的横断面研究。  

 

  关键技术  
  – 样本:19 份人血浆(16 μL)。  
  – 纯化:抗轻链磁珠一步法富集 IgG/IgA/IgM。  
  – 酶切:Trypsin + Glu-C 双酶 on-bead 消化,生成糖肽+内参肽。  
  – 定量:UHPLC-TripleQ-MS,MRM 检测 95 糖肽 + 8 内参肽;4 种稳定同位素内标校正。  
  – 验证:批内/批间 RSD、线性、回收率;与文献糖型比例对照。  

 

  创新方法  
  首次将双酶切与轻链磁珠结合,实现 IgA/IgM 糖型的高通量绝对定量,无需抗体分选。

 

4. 结果与数据解析  
主要发现  
• 线性:0.2–100 μg/mL 范围内 95 糖肽 R²>0.959。  
• 精度:批内/批间 RSD<29.6 %(全部靶点)。  
• 覆盖:定量 95 糖肽 + 8 内参肽(IgG1-4、IgA1-2、IgM)。  
• 临床比对:19 例糖型比例与已发表数据一致(偏差<10 %)。  
• 实例:IgG1-Fc 岩藻糖基化在 RA 患者↑2.1 倍(p<0.05)。  

 

数据验证  
独立批次重复,偏差<8 %;与 ELISA 总 IgG 定量相关性 r=0.98。

 

局限性  
样本量 19 例,需扩大队列;未覆盖 IgE/IgD;高甘露糖型灵敏度待提升。

 

5. 讨论与机制阐释  
机制深度  
作者提出“磁珠-双酶-内标”一体化工作流,可一次性解析抗体糖型-功能关联,为免疫学发现提供定量基础。  

 

6. 创新点与学术贡献  
  理论创新  
  建立“多同型抗体糖基化指纹”概念,为体液免疫分型提供新维度。  

 

  技术贡献  
  平台可迁移至疫苗、自身免疫、肿瘤免疫治疗监测,预计通量提升 5 倍,样本耗量降低 90 %。  

 

  实际价值  
  已授权两家 CRO 用于新药临床试验生物标志物检测;计划纳入 WHO 抗体糖基化参考方法候选。

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。